Atara Biotherapeutics Inc
NASDAQ:ATRA
ROCE
Return on Capital Employed
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
ROCE Across Competitors
ROCE Comparison
Atara Biotherapeutics Inc Competitors
Country | US |
Market Cap | 73.6m USD |
ROCE |
-168%
|
Country | US |
Market Cap | 290.8B USD |
ROCE |
16%
|
Country | US |
Market Cap | 140.7B USD |
ROCE |
13%
|
Country | US |
Market Cap | 101.4B USD |
ROCE |
22%
|
Country | US |
Market Cap | 97.8B USD |
ROCE |
15%
|
Country | AU |
Market Cap | 131.1B AUD |
ROCE |
11%
|
Country | US |
Market Cap | 82.4B USD |
ROCE |
16%
|
Country | US |
Market Cap | 43.1B USD |
ROCE |
-27%
|
Country | US |
Market Cap | 39B USD |
ROCE |
-23%
|
Country | US |
Market Cap | 27.6B USD |
ROCE |
9%
|
Country | IE |
Market Cap | 26.6B USD |
ROCE |
7%
|
Profitability Report
View the profitability report to see the full profitability analysis for Atara Biotherapeutics Inc.
See Also
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
Based on Atara Biotherapeutics Inc's most recent financial statements, the company has ROCE of -167.9%.